Whole-genome sequencing enables precise diagnosis and monitoring of rare pathogens in spinal infectionsWhole Genome Sequencing Offers New Insights for Spinal Infections

Frontiers in Medicine Published October 8, 2026 DOI ↗ Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway

Note that whole-genome sequencing provides a theoretical foundation for identifying rare pathogens in spinal infections.

This systematic review evaluates the utility of whole-genome sequencing (WGS) in the context of spinal infections. The scope of the review focuses on the technical capabilities of WGS to provide comprehensive genetic information, including precise diagnosis, outbreak tracing, and the monitoring of antimicrobial resistance.

Key findings indicate that WGS enables the reliable identification of rare and fastidious pathogens that are often difficult to characterize using conventional assays. Additionally, the technology supports clonal transmission inference and the analysis of virulence factors. These capabilities provide a more detailed genetic profile of pathogens involved in spinal infections.

While the review highlights the potential for WGS to improve clinical management and prevention strategies, it is important to note that the evidence provides a theoretical foundation for these applications. The results do not include specific clinical trial data or reported adverse events. Clinical application should be interpreted as a developing framework for precision management of spinal infections.

A systematic review looked at how whole-genome sequencing (WGS) can be used to manage spinal infections. This technology provides a detailed look at the genetic information of the germs causing these infections. It helps doctors get a more precise diagnosis and monitor for genes that make bacteria resistant to antibiotics.

One major benefit of this method is its ability to identify rare or fastidious pathogens. These are types of germs that are often very difficult to find or identify using standard laboratory tests. By using WGS, healthcare providers can better understand the specific germs involved in a patient's condition.

While this technology provides a strong theoretical foundation for managing spinal infections, it is important to note that this review did not include clinical trial data. It offers a framework for how doctors might improve prevention and treatment in the future. Patients should talk to their doctors about how these new diagnostic tools might apply to their specific care.

What this means for you:

Whole-genome sequencing helps identify rare germs and track drug resistance in spinal infections.

Common questions

How does whole-genome sequencing help with spinal infections?

Whole-genome sequencing provides comprehensive genetic information about the germs causing spinal infections. It allows for a more precise diagnosis, helps track the spread of infections, and monitors for genes that cause resistance to common antibiotics.

Can it find germs that are hard to detect?

Yes, this technology can reliably identify rare and fastidious pathogens. These are specific types of germs that are often very difficult to characterize or identify using standard, conventional laboratory assays.

Is this a new treatment for spinal infections?

This is not a new treatment but a diagnostic tool. It provides a theoretical foundation for how doctors can better manage, prevent, and control spinal infections by getting more accurate information about the germs involved.

Study Details

Study typeSystematic review

EvidenceLevel 1

PublishedOct 2026

View Original Abstract ↓

Spinal infections are a serious category of deep-seated infectious diseases that pose significant threats to human health. They are caused by a broad and complex spectrum of pathogens, including bacteria, fungi, and rare opportunistic organisms. Traditional diagnostic methods often face limitations in timeliness, accuracy, and source-tracing capability. Whole-genome sequencing (WGS), with its high resolution and throughput, provides comprehensive genetic information from pathogens, opening new avenues for precise diagnosis, outbreak tracing, and antimicrobial resistance monitoring and genomic epidemiology research in spinal infections., and enabling reliable identification of rare and fastidious pathogens that are difficult to characterize by conventional assays. This review systematically summarizes current applications of WGS in pathogen identification, clonal transmission inference, resistance gene and virulence factor analysis, and outbreak investigation. It further discusses the technical advantages, application challenges, and future development directions of WGS in outbreak tracing and resistance surveillance. Ultimately, this review aims to offer novel insights and a theoretical foundation for the precise prevention, control, and clinical management of spinal infections.

Whole-genome sequencing enables precise diagnosis and monitoring of rare pathogens in spinal infectionsWhole Genome Sequencing Offers New Insights for Spinal Infections

Common questions

Study Details

Candidiasis prevalence of 13.46% and Cryptococcal meningitis of 3.15% among HIV-positive individuals

New data shows prevalence of fungal infections in HIV patients

Clinical research that matters. Delivered to your inbox.

Whole-genome sequencing enables precise diagnosis and monitoring of rare pathogens in spinal infectionsWhole Genome Sequencing Offers New Insights for Spinal Infections

Common questions

Study Details

Candidiasis prevalence of 13.46% and Cryptococcal meningitis of 3.15% among HIV-positive individuals

New data shows prevalence of fungal infections in HIV patients

Clinical research that matters. Delivered to your inbox.

Related in Infectious Disease

From Other Specialties